Counterfeit Male Enhancement Drug Poses Risks, FDA Warns

Law360, New York (November 12, 2013, 9:45 PM EST) -- The U.S. Food and Drug Administration on Friday warned against counterfeit versions of the male sexual enhancement drug ExtenZe that could dangerously lower blood pressure in consumers with ailments such as diabetes, high blood pressure and cholesterol problems.

The FDA said the counterfeit supplement, found under the label “ExtenZe Maximum Strength” contains an ingredient called sildenafil that the FDA has approved in erectile dysfunction medications. But sildenafil can interact with prescription medications including those containing nitrates, often taken by patients with heart disease and high blood...
To view the full article, register now.